Intervention

Lifestyle therapy

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting1

Common conditions10

Lead sponsors shown5

Clinical trials

6 shown

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese PatientsNCT03472157 · 2018-06-20

Vyvanse in Children Aged 6 to 12 YearsNCT05416125 · 2023-12-20

Diet and Exercise Plus Metformin to Treat Frailty in Obese SeniorsNCT04221750 · 2021-05-14

Multifactorial Intervention on Diabetes (MIDiab Study)NCT03430284 · 2018-04-01

Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixiNCT03130426 · 2017-06-27

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With ForxigaNCT02561130 · 2015-12-01

Common conditions

Type 2 Diabetes Mellitus2 Aging1 Cirrhosis1 Diabetes Mellitus, Type 21 Frailty1 NASH - Nonalcoholic Steatohepatitis1 Obesity1 Obesity, Childhood1 Sarcopenic Obesity1 Surgery1

Leading sponsors

Population Health Research Institute2 Shandong Provincial Hospital1 University Hospital, Lille1 University of Minnesota1 VA Office of Research and Development1

Trial status mix

COMPLETED4

RECRUITING1

UNKNOWN1

Phase mix

PHASE32

PHASE42

EARLY_PHASE11

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.